Clinical Trial Update: Assessing the Efficacy and Safety of Selective Metabolically Adaptive Radiation Dose Escalation in Locally Advanced Non-Small Cell Lung Cancer Receiving Definitive Chemoradiotherapy [NA]

View source ↗

Summary

A clinical trial evaluating a selective metabolically adaptive radiation dose escalation approach in locally advanced non-small cell lung cancer patients receiv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Non-Small Cell Lung Cancer | NA | Status: ACTIVE_NOT_RECRUITING